Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.93) by 4.15 percent. This is a 33 percent increase over losses of $(3.00) per share from the same period last year.
Related Posts
Price Over Earnings Overview: Nucor
In the current market session, Nucor Inc. (NYSE:NUE) share price is at $156.62, after a 0.12% spike. Moreover,…
What Does Target’s Debt Look Like?
Shares of Target Inc. (NYSE:TGT) decreased by 8.15% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Potbelly Announces 40-Shop Agreement With Royal Restaurant Group
Potbelly Corporation (NASDAQ:PBPB), the iconic neighborhood sandwich shop, today announced the completion of a 40-unit agreement with Royal Restaurant Group, a national franchise group that successfully operates